Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-10-13FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
The FDA approved a supplemental application for AMPYRA (dalfampridine) submitted by Merz Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants [Phase 1]
Biogen conducted a Phase 1 study to evaluate safety, tolerability, and pharmacokinetics of single and multiple doses of BIIB033 (opicinumab)…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS) [Phase 2]
A Phase 2 trial of Nanocort for acute exacerbations of relapsing-remitting multiple sclerosis and clinically isolated syndrome has been term…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: JC-Virus (JCV) Antibody Program
Biogen reports completion of its JC-Virus antibody program related to multiple sclerosis.
-
FDA approval · 2016-09-30FDA Approved: LIORESAL (BACLOFEN) — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for LIORESAL (baclofen) from Amneal Pharmaceuticals LLC, signaling a change to the existing NDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Autologous Stem Cell Transplant for Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating autologous stem cell transplantation for multiple sclerosis has completed, sponsored by the Ottawa Hospita…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop [NA]
The trial update notes that a study evaluating functional electrical stimulation for foot drop in people with multiple sclerosis has complet…
-
FDA approval · 2016-09-27FDA Approved: REBIF — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for Rebif (interferon beta-1a) submitted by EMD Serono, Inc. This action updates the labeling to ref…
-
CLINICAL_TRIALS withdrawal · 2016-09-26Clinical Trial Update: Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating the safety and brain-protective effects of Theaphenon 95% (EGCG) in multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Virtual Reality and Robot Assisted Gait Training in Patients With Multiple Sclerosis [NA]
This clinical trial evaluates virtual reality and robot-assisted gait training for people with multiple sclerosis. The current status of the…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Treatment of Multiple Sclerosis With Copaxone and Albuterol [NA]
This is an update on a completed clinical trial evaluating Copaxone (glatiramer acetate) in combination with albuterol for multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor [Phase 1, Phase 2]
A Phase 1/2 clinical trial of sirolimus for relapsing-remitting multiple sclerosis has been terminated.
-
CLINICAL_TRIALS research · 2016-09-21Clinical Trial Update: Assistive Device Training in Multiple Sclerosis [NA]
Clinical trial at Portland VA Medical Center has completed evaluating assistive device training for individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis [NA]
This clinical trial update reports validation of a self-administered questionnaire for assessing calcium intake in patients with Multiple Sc…
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple Sclerosis
This update summarizes results from a completed clinical trial that examined electrophysiological measures of gait in patients with early-st…
-
CLINICAL_TRIALS research · 2016-09-12Clinical Trial Update: MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment.
A completed clinical trial evaluating a smartphone application for self-assessment in people with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2016-09-12Clinical Trial Update: Effects of GE-O System on Gait Impairments in Multiple Sclerosis Subjects [NA]
An update on a clinical trial evaluating the GE-O System for gait impairment in people with multiple sclerosis; the current trial status is …
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation [NA]
A completed clinical trial evaluated electrical stimulation as a treatment for foot drop in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: The French Multiple Sclerosis Registry
This entry notes an update to the French Multiple Sclerosis Registry, run by Hospices Civils de Lyon, covering multiple sclerosis and neurom…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: China Betaferon Adherence, Coping and Nurse Support Study
A completed clinical trial in China evaluated adherence, coping, and nurse-supported care for Betaferon (interferon beta-1b) in people with …
-
FDA approval · 2016-08-30FDA Approved: KESIMPTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Kesimpta (ofatumumab) submitted by Novartis Pharmaceuticals Corporation, expanding the regul…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise Training [Phase 1]
Phase 1 clinical trial evaluating changes in speed, endurance, and balance in women with multiple sclerosis after 4 and 8 weeks of aquatic e…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Impacts of Different Training Modes (Intense Versus Ordinary) on the Immune System and Memory Functions in pwMS [NA]
This completed clinical trial compares intense versus ordinary training modes and reports effects on immune system measures and memory funct…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Tecfidera Lymphocyte Chart Review
A completed clinical trial update reporting a chart review of lymphocyte data from patients with multiple sclerosis treated with Tecfidera (…
-
CLINICAL_TRIALS withdrawal · 2016-08-24Clinical Trial Update: A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis. [Phase 2]
A Phase 2 trial evaluating an A4I antagonist for relapsing multiple sclerosis has been withdrawn.